Sector Gamma As Novavax Inc Transaction History

Sector Gamma As

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$18.2 - $76.12 $25,680 - $107,405	1,411 Added 2.55%	56,735 $1.03 Million
Q2 2022 Aug 05, 2022	BUY	$36.28 - $75.29 $616,760 - $1.28 Million	17,000 Added 44.36%	55,324 $2.85 Million
Q1 2022 May 06, 2022	BUY	$69.73 - $142.9 $1.74 Million - $3.57 Million	24,978 Added 187.16%	38,324 $2.82 Million
Q4 2021 Feb 08, 2022	BUY	$134.56 - $217.97 $309,757 - $501,766	2,302 Added 20.84%	13,346 $1.91 Million
Q3 2021 Oct 29, 2021	SELL	$177.8 - $270.58 $459,079 - $698,637	-2,582 Reduced 18.95%	11,044 $2.29 Million
Q2 2021 Aug 04, 2021	BUY	$121.0 - $257.67 $1.65 Million - $3.51 Million	13,626 New	13,626 $2.89 Million
Q1 2021 May 10, 2021	SELL	$112.98 - $319.93 $1.3 Million - $3.68 Million	-11,500 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$78.74 - $139.5 $905,509 - $1.6 Million	11,500 New	11,500 $1.28 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $666M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Sector Gamma As, based on Form 13F filings with the SEC.

Stay updated on Sector Gamma As with notifications on news.